Replimune Group, Inc.
REPL
$10.26
$0.262.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 70.22% | 54.05% | 22.04% | 9.21% | 6.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.62% | 24.90% | 11.60% | 5.42% | 8.44% |
| Operating Income | -38.62% | -24.90% | -11.60% | -5.42% | -8.44% |
| Income Before Tax | -45.71% | -27.27% | -14.60% | -8.86% | -7.25% |
| Income Tax Expenses | 14.71% | 126.09% | 14.71% | -32.98% | 41.67% |
| Earnings from Continuing Operations | -45.65% | -27.37% | -14.60% | -8.71% | -7.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.65% | -27.37% | -14.60% | -8.71% | -7.30% |
| EBIT | -38.62% | -24.90% | -11.60% | -5.42% | -8.44% |
| EBITDA | -39.55% | -25.17% | -11.44% | -4.13% | -8.05% |
| EPS Basic | -13.28% | 1.51% | 5.21% | 2.49% | 0.82% |
| Normalized Basic EPS | -13.33% | 1.59% | 5.22% | 2.33% | 0.88% |
| EPS Diluted | -13.28% | 1.51% | 5.21% | 2.49% | 0.82% |
| Normalized Diluted EPS | -13.33% | 1.59% | 5.22% | 2.33% | 0.88% |
| Average Basic Shares Outstanding | 27.71% | 28.44% | 20.66% | 11.85% | 9.11% |
| Average Diluted Shares Outstanding | 27.71% | 28.44% | 20.66% | 11.85% | 9.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |